NCT02114684View on ClinicalTrials.gov

Improving Retreatment Success (IMPRESS)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

July 31, 2017

Study Completion Date

July 17, 2017

Conditions
Recurrent Tuberculosis
Interventions
DRUG

moxifloxacin

\[isoniazid (H), rifampicin (R), pyrazinamide (Z), moxifloxacin (M)\]

Trial Locations (1)

4001

CAPRISA eThekwini Clinical Research Site (eCRS), Durban

All Listed Sponsors
lead

Centre for the AIDS Programme of Research in South Africa

NETWORK

NCT02114684 - Improving Retreatment Success (IMPRESS) | Biotech Hunter | Biotech Hunter